Experimental: Sacubitril/Allisartan and Amlodipine Group

DRUG2 trials

Sponsors

Shenzhen Salubris Pharmaceuticals Co., Ltd.

Conditions

Essential Hypertension

Phase 3

Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Amlodipine

CompletedNCT07704684

Shenzhen Salubris Pharmaceuticals Co., Ltd.Essential Hypertension

Start: 2023-06-28End: 2025-09-08Updated: 2026-07-15

Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Sacubitril/Allisartan

CompletedNCT07704697

Shenzhen Salubris Pharmaceuticals Co., Ltd.Essential Hypertension

Start: 2024-11-23End: 2025-11-24Updated: 2026-07-15